Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model

This publication has 18 references indexed in Scilit:

• Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity
  Infection and Immunity, 2005
• Recombinant antibodies: a natural partner in combinatorial antifungal therapy
  Vaccine, 2004
• Immunogenicity and protective effect of recombinant enolase ofCandidaalbicansin a murine model of systemic candidiasis
  Medical Mycology, 2004
• Candida albicans TDH3 gene promotes secretion of internal invertase when expressed in Saccharomyces cerevisiae as a glyceraldehyde‐3‐phosphate dehydrogenase‐invertase fusion protein
  Yeast, 2003
• Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of aCandida albicansVaccine
  Infection and Immunity, 2002
• Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorbtion with GM-CSF on alum
  Vaccine, 2000
• Protection against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective Antibody
  Infection and Immunity, 2000
• Purification of a biologically active recombinant glyceraldehyde 3-phosphate dehydrogenase from Candida albicans
  FEMS Microbiology Letters, 1999
• Candida albicansMannan Extract–Protein Conjugates Induce a Protective Immune Response against Experimental Candidiasis
  The Journal of Infectious Diseases, 1999
• Clinical strains ofCandida albicansexpress the surface antigen glyceraldehyde 3-phosphate dehydrogenase in vitro and in infected tissues
  FEMS Immunology & Medical Microbiology, 1999